New research from Bidwells, working with YouGov and Advanced Oxford, tracks the growing relationship between life science and technology companies
Convergence between life sciences and technology remains at an early stage, but the availability of patient data has expanded at an enormous pace, as has the data generated by life sciences companies through their R&D activities. This data facilitates the application of technology, both at the drug discovery stage, but also in the advancement of the potential for personalisation of patient treatment. Technical advances in AI and big data have supported the leveraging of data in tech driven drug discovery, clinical trials and patient management. The pace of learning in these areas is building specialist knowledge in life science applications of technology, both in large companies, but particularly through the creation of start ups and spin-outs.
This new research examines the relationships, trends and examines the consequences for collaboration and co-location.Read the report here